Folgen
Rajiv Agarwal
Rajiv Agarwal
Indiana Univeristy
Bestätigte E-Mail-Adresse bei iu.edu
Titel
Zitiert von
Zitiert von
Jahr
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
58642019
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, P Rossing, P Kolkhof, ...
New England journal of medicine 383 (23), 2219-2229, 2020
21022020
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
B Pitt, G Filippatos, R Agarwal, SD Anker, GL Bakris, P Rossing, A Joseph, ...
New England Journal of Medicine 385 (24), 2252-2263, 2021
12152021
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
D De Zeeuw, R Agarwal, M Amdahl, P Audhya, D Coyne, T Garimella, ...
The Lancet 376 (9752), 1543-1551, 2010
9212010
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States
R Agarwal, AR Nissenson, D Batlle, DW Coyne, JR Trout, DG Warnock
The American journal of medicine 115 (4), 291-297, 2003
7562003
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
R Agarwal, G Filippatos, B Pitt, SD Anker, P Rossing, A Joseph, P Kolkhof, ...
European heart journal 43 (6), 474-484, 2022
7352022
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial
R Thadhani, E Appelbaum, Y Pritchett, Y Chang, J Wenger, H Tamez, ...
Jama 307 (7), 674-684, 2012
7162012
Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial
GL Bakris, R Agarwal, JC Chan, ME Cooper, RT Gansevoort, H Haller, ...
Jama 314 (9), 884-894, 2015
6722015
Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis
R Agarwal, JE Bills, TJW Hecht, RP Light
Hypertension 57 (1), 29-38, 2011
5452011
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
R Agarwal, M Acharya, JIN Tian, RL Hippensteel, JZ Melnick, P Qiu, ...
Kidney international 68 (6), 2823-2828, 2005
5222005
Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial
J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ...
Jama 318 (5), 432-442, 2017
5212017
Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial
GL Bakris, B Pitt, MR Weir, MW Freeman, MR Mayo, D Garza, Y Stasiv, ...
Jama 314 (2), 151-161, 2015
5072015
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial
P Alborzi, NA Patel, C Peterson, JE Bills, DM Bekele, Z Bunaye, RP Light, ...
Hypertension 52 (2), 249-255, 2008
4892008
Dry-weight reduction in hypertensive hemodialysis patients (DRIP) a randomized, controlled trial
R Agarwal, P Alborzi, S Satyan, RP Light
Hypertension 53 (3), 500-507, 2009
4682009
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
R Agarwal, P Kolkhof, G Bakris, J Bauersachs, H Haller, T Wada, ...
European heart journal 42 (2), 152-161, 2021
4622021
Research priorities for heart failure with preserved ejection fraction: national heart, lung, and blood institute working group summary
SJ Shah, BA Borlaug, DW Kitzman, AD McCulloch, BC Blaxall, R Agarwal, ...
Circulation 141 (12), 1001-1026, 2020
3892020
Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease
R Minutolo, R Agarwal, S Borrelli, P Chiodini, V Bellizzi, F Nappi, ...
Archives of internal medicine 171 (12), 1090-1098, 2011
3892011
Rapid, fluorimetric–liquid chromatographic determination of malondialdehyde in biological samples
R Agarwal, SD Chase
Journal of Chromatography B 775 (1), 121-126, 2002
3672002
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
K Matsushita, SH Ballew, AYM Wang, R Kalyesubula, E Schaeffner, ...
Nature Reviews Nephrology 18 (11), 696-707, 2022
3472022
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
R Agarwal, N Vasavada, NG Sachs, S Chase
Kidney international 65 (6), 2279-2289, 2004
3432004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20